Beyond Thinking
Welcome to Beyond Blue’s Thought Leadership Hub, where we highlight complex concepts with clarity and showcase our commitment to delivering excellence with ease. Explore our insights, discover innovative perspectives and join us on a journey to navigate the intricate with confidence.
Spotlight on BTK inhibitors in MS
In recent years, interest in BTK inhibitors (BTKi) for MS has surged, with hopes that they could offer a new way to tackle the underlying drivers of the disease. But the journey, so far, has been a rollercoaster, and the delayed FDA decision on tolebrutinib marks the...
Smarter Tools, Smarter Care: How Innovation is Transforming Prostate Cancer
From early detection to advanced therapy, prostate cancer care is being reshaped by smarter tools that provide deeper insight and more precise interventions. These advances are enabling clinicians to act sooner, tailor treatment more accurately, and expand options for...
The Power of Words: In sickness and in health
Why is it that some people will happily stick to collagen powders and herbal elixirs but skip life-saving medication? This puzzling question became the spark for our self-funded study. Watching my own mother consistently and purposefully forget her prescriptions,...
Data dump to strategic clarity: Make patient chart audits work for you
When you're sitting on hundreds, sometimes thousands, of patient records, the challenge isn’t just collecting the data, or even analysing it. It’s making it usable. Beyond Blue helps you turn complex chart audit data into clear, actionable insight. No more 300-slide...
More Bang for Your Behavioural Buck: Connecting COM-B to the Behaviour Change Wheel and Behaviour Change Taxonomy
COM-B has rightly become a cornerstone of behaviour change in market research projects. It allows a seamless transition from insight to practical implementation by pinpointing where to focus behaviour change efforts. While COM-B is widely used, integrating it with the...
ASCO 2025: Key market shifts and strategic considerations
ADCs step into first-line mBC ASCO 2025 highlighted the growing role of ADCs in reshaping metastatic breast cancer treatment. Two key trials, DESTINY-Breast09 and ASCENT-04, showed strong efficacy for ADCs in 1L HER2+ mBC and PD-L1+ TNBC respectively, raising the...
The Typing Tool Trap: How to make it work for you
At Beyond Blue, we believe segmentation should be more than a strategic exercise; it should serve as a catalyst for action. However, even the most intuitive segmentation framework can falter if the tools used to implement it create friction for stakeholders. That’s...
ASCO 2025: Sneak peek at key themes for this year’s conference
As ASCO 2025 approaches, all eyes are on the pivotal trials that could shift standards, reshape narratives, and spark new questions for oncology strategy. From groundbreaking trials in mBC to paradigm-challenging immunotherapy in colon cancer, this year’s line-up is...
Launch Readiness: 5 essentials to get It right
The final 12 months leading up to a launch are intense and demanding. With multiple workstreams, changing market dynamics, and fast-moving priorities, there’s no room for guesswork. Here’s how to stay sharp and set your launch up for success: 1. Build a Campaign that...
